Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Parkinson disease”

The Validity and Reliability of an Improved Paper Grasping Test for Parkinson's DiseaseCompleted
NCT07772622N/AUpdated Aug 19, 2026
Sponsor: Sanko University
Parkinson's Disease · Validity · Reability
Turkey (Türkiye)
Pimavanserin vs. Quetiapine for Treatment of Parkinson's PsychosisRecruiting
NCT04373317Phase 4Updated Aug 19, 2026
Sponsor: VA Office of Research and Development
Parkinson's Disease Psychosis
United States
Agricultural Health Study Follow-upCompleted
NCT01399411N/AUpdated Aug 19, 2026
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Asthma · Parkinson's Disease
United States
A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.Recruiting
NCT07630545Phase 1Updated Aug 19, 2026
Sponsor: Mission Therapeutics
Parkinson's Disease (PD) · Mild to Moderate Parkinson's Disease · Early Stage Parkinson's Disease
Australia, France, Germany, United Kingdom
Exploring the Efficacy of the Effortful Swallow Maneuver for Improving Swallowing in People With PDNot Yet Recruiting
NCT07773025NAUpdated Aug 19, 2026
Sponsor: University of Alberta
Dysphagia · Parkinson Disease (PD)
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)Recruiting
NCT06996652Phase 2Updated Aug 19, 2026
Sponsor: Yale University
REM Sleep Behavior Disorder
United States, Canada
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseaseRecruiting
NCT06976268Phase 2, Phase 3Updated Aug 19, 2026
Sponsor: Biohaven Therapeutics Ltd.
Parkinson Disease
United States
Bracing for Walking in Parkinson's DiseaseCompleted
NCT03192046NAUpdated Aug 18, 2026
Sponsor: University of Texas Southwestern Medical Center
Gait Disorders, Neurologic · Parkinson Disease
United States
A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)Terminated
NCT05665595Phase 3Updated Aug 18, 2026
Sponsor: Merck Sharp & Dohme LLC
Melanoma
United States, Argentina, Australia, Austria, Belgium +21 more
Home-Based Exercise Programs for Fall Prevention in Parkinson DiseaseCompleted
NCT07590700NAUpdated Aug 18, 2026
Sponsor: Uludag University
PARKINSON DISEASE (Disorder) · Falls Prevention · Exercise
Turkey (Türkiye)
Evaluation and Treatment of Neurosurgical DisordersRecruiting
NCT00060541N/AUpdated Aug 18, 2026
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Neurologic Disorders
United States
Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)Recruiting
NCT06482268Phase 1Updated Aug 17, 2026
Sponsor: University of California, San Diego
PD - Parkinson's Disease
United States
Imaging Biomarkers in Parkinson s DiseaseCompleted
NCT01496599N/AUpdated Aug 17, 2026
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Parkinson Disease
United States
Positron Emission Tomography (PET) Imaging in People With Gaucher MutationsCompleted
NCT00302146N/AUpdated Aug 17, 2026
Sponsor: National Human Genome Research Institute (NHGRI)
Parkinson Disease · Gaucher Disease
United States
PET Imaging of Cyclooxygenases in Neurodegenerative Brain DiseaseRecruiting
NCT04396873Phase 1Updated Aug 17, 2026
Sponsor: National Institute of Mental Health (NIMH)
Parkinson's Disease · Dementia · Alzheimer's Disease · ALS
United States
Clinical and Physiological Studies of Tremor SyndromesCompleted
NCT03027310N/AUpdated Aug 17, 2026
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Parkinson Disease · Dystonia · Essential Tremor
United States
A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's DiseaseRecruiting
NCT07322887Phase 2Updated Aug 17, 2026
Sponsor: GEN İlaç ve Sağlık Ürünleri A.Ş.
Parkinson's Disease (PD)
Netherlands
Neuromodulation for Patients With Parkinson's DiseaseNot Yet Recruiting
NCT07767006NAUpdated Aug 17, 2026
Sponsor: Felipe Fregni, MD, PhD, MPH
Adults With Parkinson's Disease
United States
A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based ChemotherapyActive Not Recruiting
NCT03076554Phase 2Updated Aug 17, 2026
Sponsor: National Cancer Institute (NCI)
Thymoma · Thymic Carcinoma
United States
Unilateral and Staged Bilateral Pallidothalamic Tractotomy Using Exablate MRgFUS in Advanced Parkinson's Disease.Not Yet Recruiting
NCT07764874NAUpdated Aug 14, 2026
Sponsor: InSightec
Parkinson Disease
A Pilot Study of In-lab Dynamic Standing in Parkinson's DiseaseRecruiting
NCT07543861Phase 1Updated Aug 14, 2026
Sponsor: University of Michigan
Parkinson Disease
United States
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)Recruiting
NCT06312176Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +35 more
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)Active Not Recruiting
NCT04736706Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Renal Cell
United States, Australia, Brazil, Canada, Chile +30 more
Using the EHR to Advance Genomic Medicine Across a Diverse Health SystemRecruiting
NCT06377033NAUpdated Aug 14, 2026
Sponsor: University of Pennsylvania
Genetic Predisposition · Paraganglioma · Pheochromocytoma · ALS
United States
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)Recruiting
NCT06966700Phase 3Updated Aug 14, 2026
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms · Triple Negative Breast Neoplasms · HR Low-Positive/HER2-Negative Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +34 more

Previous page Next page